The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pilot study to enhance FDG-PET imaging of prostate cancers with the metabolic inhibitor ranolazine.
 
Isabel R. Schlaepfer
Patents, Royalties, Other Intellectual Property - Reagents of the University of Colorado; Reagents of the University of Colorado (Inst)
 
Elizabeth R Kessler
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Medivation/Astellas; Pfizer (Inst)
 
Jennifer J Kwak
No Relationships to Disclose
 
Lauren Liebman*
No Relationships to Disclose
 
Paul Maroni
Consulting or Advisory Role - Janssen
Research Funding - Astellas Medivation (Inst); Dendreon (Inst); GenomeDx (Inst); Progenics (Inst)
Travel, Accommodations, Expenses - American Urological Association; Grand Rounds
 
Ramesh Karki
No Relationships to Disclose
 
Dan Lopez Paniagua
No Relationships to Disclose
 
Phillip Koo**
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Janssen
 
Francisco G. La Rosa
Consulting or Advisory Role - Precision Biopsy
 
Dexiang Gao
No Relationships to Disclose
 
L. Michael Glode
Leadership - Gonex; ProTechSure Scientific
Stock and Other Ownership Interests - Aurora Oncology; Gonex; ProTechSure Scientific
Consulting or Advisory Role - Bayer; Janssen; Seagen
Patents, Royalties, Other Intellectual Property - Patents held by the University of Colorado in my name relating to GnRH and EGF toxin conjugates, Silibinin
Travel, Accommodations, Expenses - Janssen
 
Thomas W. Flaig
Leadership - Aurora Oncology
Stock and Other Ownership Interests - Aurora Oncology
Honoraria - BN ImmunoTherapeutics
Consulting or Advisory Role - GTX
Research Funding - Agensys; Aragon Pharmaceuticals; Astellas Pharma; astrazeneca/MedImmune; Bavarian Nordic; Bristol-Myers Squibb; Dendreon; Exelixis; GTx; Janssen Oncology; La Roche-Posay; Lilly; Medivation; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen; Sotio; Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents related in which I am an inventor. These are related to early-stage bladder cancer treatment and detection. Neither is commercialized or licensed at this time.
 
Elaine Tat Lam
Consulting or Advisory Role - Astellas Pharma; Calithera Biosciences
Research Funding - Advaxis (Inst); Argos Therapeutics (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Constellation Pharmaceuticals (Inst); Exelixis (Inst); Merck (Inst); Peloton Therapeutics (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Constellation Pharmaceuticals